Cambridge Investment Research Advisors’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-8,741
Closed -$894K 1486
2014
Q4
$894K Buy
8,741
+1,284
+17% +$123K 0.03% 530
2014
Q3
$645K Sell
7,457
-644
-8% -$57K 0.02% 684
2014
Q2
$731K Sell
8,101
-14,103
-64% -$1.06M 0.03% 573
2014
Q1
$1.64M Buy
22,204
+1,642
+8% +$115K 0.06% 305
2013
Q4
$1.4M Buy
20,562
+3,870
+23% +$252K 0.06% 314
2013
Q3
$1.02M Sell
16,692
-263
-2% -$16K 0.04% 361
2013
Q2
$945K Buy
+16,955
New +$980K 0.05% 335

Cambridge Investment Research Advisors's COV Position: Q1 2015 in Review

Cambridge Investment Research Advisors sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 8,741 shares — an estimated $894K sold.

Cambridge Investment Research Advisors first reported a position in COV in Q2 2013 and held it in 7 quarters. The position peaked at $1.64M in Q1 2014. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

  • Cambridge Investment Research Advisors reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 8,741 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $894K.
  • Cambridge Investment Research Advisors first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 7 quarters.
  • Cambridge Investment Research Advisors's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $1.64M in Q1 2014.
  • 1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2015, filed 4 May 2015.